Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
February 12, 2024 08:32 ET
|
Neuronetics
MALVERN, Pa., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
February 06, 2024 08:28 ET
|
Neuronetics
MALVERN, Pa., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory
December 18, 2023 08:49 ET
|
Neuronetics
MALVERN, Pa., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar TMS Receives Expanded Regulatory Approval in Japan
December 04, 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
November 13, 2023 08:57 ET
|
Neuronetics
MALVERN, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
November 09, 2023 08:32 ET
|
Neuronetics
MALVERN, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
October 16, 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
September 12, 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
August 21, 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform
August 14, 2023 09:02 ET
|
Neuronetics
MALVERN, Pa., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...